Topical Therapies for Pediatric AD
A review of topical treatments for pediatric atopic dermatitis, from calcineurin inhibitors like pimecrolimus and tacrolimus to newer options like the PDE4 inhibitor crisaborole and the JAK inhibitor ruxolitinib. These therapies vary in molecular weight, systemic absorption, and efficacy in reducing inflammation and itch.
Peggy Vernon, RN, MA, CPNP, DCNP, FAANP, FSDNP, is a certified pediatric nurse practitioner, a psychiatric clinical nurse specialist, and a certified dermatology nurse practitioner.
Please note: An additional topical treatment has been approved for pediatric atopic dermatitis since the conference presentation in this video. Visit https://www.hmpgloballearningnetwork.com/site/thederm/fda-alerts/fda-approves-tapinarof-cream-1-atopic-dermatitis-adults-and-children for more information.
© 2025 HMP Global. All Rights Reserved.
Any views and opinions expressed are those of the author(s) and/or participants and do not necessarily reflect the views, policy, or position of The Dermatologist or HMP Global, their employees, and affiliates.
The APP Institute is dedicated to educating and informing advanced practice providers on clinical topics and practical issues to support the profession and improve the quality of patient care across the spectrum of dermatology.
The Derm APP is designed for Advanced Practice Providers who specialize in Dermatology, to further their education and increase their knowledge to achieve better patient outcomes. Explore cutting-edge research, innovative treatment options, and new therapeutic methods, while remaining focused on the fundamental principles and terminology associated with dermatology. Engage year-round with The Dermatologist to access clinical insights, interactive features, research news updates, accredited continuing education programs, and more.
